You are about to leave the Clinical Value website now.

Cancel

Recent Articles

Cancer genomic testing | Jennifer’s story

Comprehensive genomic profiling (CGP) is a method of cancer genomic testing used to reveal the unique set of mutations within the cancer’s DNA which determine how…

READ MORE
8 December 2022

My greatest hope | Mr Yan’s liver cancer story

Mr Yan was diagnosed with hepatocellular carcinoma (HCC) in 2018. He was a healthy, active person as a competitive skier, and his diagnosis was completely unexpected.…

READ MORE
8 December 2022

Hepatocellular carcinoma – the ‘silent killer’ disease infographic

Chronic liver disease (CLD) is on the rise. CLD can progress to Hepatocellular Carcinoma (HCC), a type of liver cancer. What are the risk factors for…

READ MORE
8 December 2022

Hepatocellular carcinoma – the ‘silent killer’ | Part 2

How did Taiwan halve the incidence of hepatocellular carcinoma (HCC) in a decade? HCC is the primary form of liver cancer, with 72% of cases diagnosed…

READ MORE
8 December 2022

Hepatocellular carcinoma – the ‘silent killer’ | Part 1

Do you know what can cause hepatocellular carcinoma, the primary form of liver cancer? In Asia, contaminated food has historically been linked with the disease and…

READ MORE
8 December 2022

Liver cancer: the global impact

Hepatocellular carcinoma numbers continue to rise globally, due to major risk factors such as Hepatitis B and C, and fatty liver disease. Hear Liver Patients International’s…

READ MORE
8 December 2022

Breaking the link between chronic liver disease and liver cancer

Millions of people are living with chronic liver disease. Can the link between chronic liver disease and liver cancer be broken through partnership?

READ MORE

You May Also Like

13 May 2024

No woman left behind: Increasing access to testing for cervical cancer elimination

Read More
13 May 2024

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong

Read More

Be the first to receive updates, event opportunities, and thought leadership insights.